MetaADEDB 2.0 @ LMMD
Isoproterenol
(IROWCYIEJAOFOW-UHFFFAOYSA-N)
Structure
SMILES
CC(NCC(c1ccc(c(c1)O)O)O)C.Cl
Molecular Formula:
C11H18ClNO3
Molecular Weight:
247.719
Log P:
2.3221
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
5
TPSA:
72.72
CAS Number(s):
51-30-9; 949-36-0; 5984-95-2
Synonym(s)
1.
Isoproterenol
2.
Isoprenaline
3.
Isopropylarterenol
4.
4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol
5.
Euspiran
6.
Isadrin
7.
Isadrine
8.
Isopropyl Noradrenaline
9.
Isopropylnoradrenaline
10.
Isopropylnorepinephrine
11.
Isoproterenol Hydrochloride
12.
Isoproterenol Sulfate
13.
Isuprel
14.
Izadrin
15.
Norisodrine
16.
Novodrin
17.
Hydrochloride, Isoproterenol
18.
Noradrenaline, Isopropyl
19.
Sulfate, Isoproterenol
External Link(s)
MeSHD007545
PubChem Compound5807
13701
57513594
ChEBI31453
CHEMBLCHEMBL1711
KEGGdr:D01390
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
2AphasiaFAERS: 2US FAERS
3Back PainFAERS: 2US FAERS
4HypotensionFAERS: 2US FAERS
5Incorrect dose administeredFAERS: 2US FAERS
6SyncopeFAERS: 2US FAERS
7TremorFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
8Accidental overdoseFAERS: 1US FAERS
9BradycardiaFAERS: 1US FAERS
10Chest PainFAERS: 1US FAERS
11Chest discomfortFAERS: 1US FAERS
12Drug exposure during pregnancyFAERS: 1US FAERS
13Endotracheal intubation complicationFAERS: 1US FAERS
14FractureFAERS: 1US FAERS
15MalaiseFAERS: 1US FAERS
16Medication ErrorFAERS: 1US FAERS
17No adverse eventFAERS: 1US FAERS
18Product administration interruptedFAERS: 1US FAERS
19Product prescribing errorFAERS: 1US FAERS
20Sinus TachycardiaFAERS: 1US FAERS
21StressFAERS: 1US FAERS
22Syringe issueFAERS: 1US FAERS
23TachycardiaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
24Therapy non-responderFAERS: 1US FAERS
25Wrong drug administeredFAERS: 1US FAERS
26AstheniaCanada Vigilance: 1Canada Vigilance
27BronchospasmCanada Vigilance: 1Canada Vigilance
28Burning sensationCanada Vigilance: 1Canada Vigilance
29ChillsCanada Vigilance: 1Canada Vigilance
30DizzinessCanada Vigilance: 1Canada Vigilance
31Drug level increasedCanada Vigilance: 1Canada Vigilance
32Myocardial InfarctionCanada Vigilance: 1Canada Vigilance
33Respiratory arrestCanada Vigilance: 1Canada Vigilance
34VomitingCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.